Orchard Therapeutics announced the appointment of John Curnutte, M.D., Ph.D., to its board of directors. Most recently, Dr. Curnutte served as executive vice president of research and development for Portola Pharmaceuticals, where he worked as the lead executive officer for all R&D activities.